Sanofi SA said it has agreed to settle approximately 4,000 lawsuits accusing the French drugmaker of selling its Zantac heartburn medicine without warning patients that it could cause cancer.
The pact, the first major resolution of cases related to the product, will apply to litigation pending in courts in states other than Delaware, the company said in a statement. Earlier, people familiar with the negotiations told Bloomberg that as many as 5,000 cases could eventually be covered by the deal.
The settlement should help soothe the jangled nerves of investors concerned about the fallout of